The purpose of this study is to determine whether mesalamine is effective in the treatment of uncomplicated diverticular disease by reducing the pain.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The change in intensity of lower abdominal pain during the first four weeks of treatment (SPID 0-28)
Timeframe: 4 weeks